Sianny Herawati
Department of Clinical Pathology, Faculty of Medicine, Universitas Udayana/Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar

Published : 4 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 4 Documents
Search

The Concordance of Platelet Counts on Hematology Analyzer with Thrombocytopenia Sample with Platelet Clump I Putu Yuda Prabawa; Anak Agung Wiradewi Lestari; I Nyoman Wande; Ni Nyoman Mahartini; Sianny Herawati; Tzeto Han Cong
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 1 (2025)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i1.2437

Abstract

Pseudo-thrombocytopenia is a pre-analytical issue commonly observed in clinical laboratory settings due to platelet aggregation or clumps. In cases of thrombocytopenia, it is essential to conduct a platelet count via Peripheral Blood Smear (PBS) to identify clumping and subsequently re-evaluate the platelet count. The examination of platelets can now be carried out through different methodologies offered by Hematology Analyzers, such as PLT-I, PLT-O, and PLT-F. The primary objective of this research was to evaluate the correlation and agreement of platelet count findings (PLT-I, PLT-O, and PLT-F) in samples displaying flagged platelet clumps between a Hematology Analyzer and PBS at Prof. dr. I.G.N.G. Ngoerah General Hospital, Bali. An analytical cross-sectional observational study was conducted on 71 samples of thrombocytopenia with platelet clump flagging on the Sysmex® XN-1000 Series Hematology Analyzer at Prof. dr. I. G. N. G. Ngoerah Hospital. SPSS version 26.0 and MedCalc were used to conduct statistical analysis. There was a significant difference in the PLT clump Fluorescence index (p = 0.001) between the sample groups with and without the clump, and there was a strong positive correlation of the PLT count results between the Hematology Analyzer (p <0.001) and PBS in the sample groups with and without the clump. The Bland-Altman mean bias was lowest in the sample group without clumps against PLT-I (0.39x103/ml; 95% LOA: -57.05-57.83) and highest in the sample group with a clump to PLT-F (105.38x103/ml; 95% LOA: -14.7-225.46). There is a strong positive correlation and concordance of platelet count results between the Hematology Analyzer and PBS. However, there is no concordance between the platelet count results from the Hematology Analyzer and PBS in the clump group.
High Neutrophil Fluorescence Dispersion Width as A Predictor of Positive Blood Culture in Early-Onset Neonatal Sepsis Marchelly Sharlyn Irianne Lewu; I Nyoman Wande; Ni Nyoman Mahartini; Sianny Herawati; Ni Kadek Mulyantari
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 2 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i2.2507

Abstract

Early diagnosis is needed in patients with early-onset neonatal sepsis (EOS). The blood culture method has disadvantages including a long completion time. The Width of dispersion of neutrophil fluorescence (NE-WY) values increased in patients with EOS. However, research assessing the NE-WY as a predictor of positive blood culture is still limited. This research aimed to determine the value of NE-WY as a predictor factor for positive blood culture in patients with EOS. Case-control research using secondary data from 70 medical records was carried out on SNAD patients from March  to June 2022. The variables measured were the NE-WY value, blood culture results, and gender. Data analysis consisted of descriptive analysis, ROC, chi-square test, and logistic regression. The present study revealed that out of 70 patients with EOS positive blood cultures accounted for 37.1%. The patients with positive blood cultures were dominated by women (80.8%) and NE-WY values >800.5 (73.1%). NE-WY had an AUC value of 0.763 and p <0.01. The sensitivity and specificity rate of NE-WY were 73.1% and 61.4% respectively with the best cutoff being 800.5. Multivariate analysis showed that the NE-WY variable was significantly associated (p <0.05) with blood culture results, which had an adjusted OR value of 3.97 (95% CI 1.283-12.327). To conclude, NE-WY can differentiate the results between positive and negative blood cultures at a cut-off of 800.5 and has moderate or acceptable manifestations as a diagnostic test tool.
MONOCYTE CELL COMPLEXITY (MO-X) AS A PREDICTOR OF DIABETIC ULCERS IN TYPE 2 DIABETES MELLITUS PATIENTS I Made Bayu Wiratama; I Nyoman Wande; I Nyoman Gde Sudana; Sianny Herawati; Ni Kadek Mulyantari
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 3 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i3.2703

Abstract

Diabetic foot ulcers (DFUs) are a common complication of type 2 diabetes mellitus associated with chronic inflammation and impaired wound healing. Monocyte cell complexity (MO-X), a cell population data parameter obtained from automated hematology analyzers, may reflect immune activation and inflammatory status. This case-control study was conducted at Ngoerah Hospital, Denpasar, from February to June 2024. Fifty-four participants were enrolled, including 27 patients with DFUs and 27 controls without DFUs. Monocyte cell complexity (MO-X) values were measured using a Sysmex XN-3000 analyzer. Data were analyzed using receiver operating characteristic (ROC) curve analysis, chi-square test, and odds ratio calculation. Monocyte cell complexity (MO-X) values were significantly higher in the DFUs group than in the control group (p < 0.001). The ROC analysis demonstrated an area under the curve (AUC) of 0.721 (95% CI: [6.22–126.06]), with an optimal cutoff value of 117.45, yielding 77.8% sensitivity and 88.9% specificity. Patients with elevated MO-X values had a 28-fold higher risk of DFUs (OR = 28.00; 95% CI: 6.22–126.06; p <0.001). Elevated MO-X values are strongly associated with the presence of DFUs, suggesting that MO-X may serve as a rapid and non-invasive biomarker for identifying diabetic patients at increased risk of ulcer development. Further multicenter studies are required to validate these findings.
Diagnostic Value of NE-WY and MO-WY for Rapid Identification Acute Leukemia Fisky Gilbert Asa Maramis; Anak Agung Wiradewi Lestari; I Nyoman Wande; I Nyoman Gde Sudana; Sianny Herawati
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 2 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i2.2830

Abstract

Rapid identification of acute leukemia is essential for its management. In resource-limited settings, simple, fast, and non-invasive initial screening methods are crucial for early detection. Cell population data (CPD) obtained from an automated hematology analyzer provides a new approach to identify acute leukemia quickly. Determine the ability of the width of dispersion of neutrophil fluorescence (NE-WY) and the width of dispersion of monocyte fluorescence (MO-WY), in rapidly identifying acute leukemia. The research was performed at Ngoerah Hospital Bali, focusing on patients recently diagnosed with acute leukemia. NE-WY and MO-WY values were measured using the Sysmex XN-3000 device. The study included healthy controls who had a medical check-up, and reactive controls, specifically patients with infections or inflammatory conditions. Patients who relapsed or previously received chemotherapy were excluded. A total of 228 subjects were involved in this study: 78 acute leukemia patients, 80 healthy controls, and 70 reactive controls. Distinguishing leukemia from healthy controls, the NE-WY cut-off value was 689, with sensitivity; 92.3%, specificity; 100% (p <0.001). While distinguishing from reactive controls, the cut-off value of NE-WY 857.5 was obtained, with sensitivity; 70.5%, specificity; 82.9% (p <0.001). In distinguishing leukemia from healthy controls, the cut-off value MO-WY 804 was obtained, with sensitivity; 52.6%, specificity; 96.3% (p <0.001). While distinguishing from reactive controls, the cut-off value of MO-WY 901 was obtained, with sensitivity; 46.1%, specificity; 85.7% (p = 0.299). NE-WY values indicated superior sensitivity and specificity compared to MO-WY in the early detection of acute leukemia.